Stability and Crestal Bone Changes Around Implants Placed at Crestal Versus Subcrestal Level in Controlled Type Two Diabetic Patients
Evaluation of Stability and Crestal Bone Changes Around Implants Placed at Crestal Versus Subcrestal Level in Controlled Type Two Diabetic Patients (Randomized Clinical Trial)
1 other identifier
interventional
22
1 country
1
Brief Summary
The objective of this study is to assess clinically the peri implant tissues, the radiological marginal bone loss and the stability around implants placed at the crestal versus the subcrestal level in type 2 controlled diabetic patients using cone beam computed tomography
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 23, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 23, 2021
CompletedFirst Submitted
Initial submission to the registry
November 7, 2021
CompletedFirst Posted
Study publicly available on registry
November 18, 2021
CompletedNovember 18, 2021
November 1, 2021
6 months
November 7, 2021
November 7, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
change in Implant stability
Implant stability will be measured again by Osstell at 3 different directions (buccal, mesial and distal) at the time of implant loading (after 3 months from implant placement).
at baseline and 3 months
change in margianl bone level
CBCT will be done Marginal bone loss in all aspects (mesial, distal buccal and lingual) The difference in distance from bone crest to apical end of the implant will be assessed at each follow up period then the mean will be calculated for mesial and distal and also for buccal and lingual.
at baseline, 3rd and 6th months
Study Arms (2)
Crestally positioned implants
EXPERIMENTALSubcrestally positioned implants
ACTIVE COMPARATORInterventions
Mid crestal incision will be performed and full-thickness envelope flap will be elevated to expose the alveolar ridge (no releasing incisions will be made). Implant site will be prepared according to the manufacturer's instructions under sterile copious irrigation Implants will be placed at crestal level
Implants will be placed 1mm subcrestally
Eligibility Criteria
You may qualify if:
- Type 2 controlled diabetic patients
- Patients with at least one missing tooth in lower jaw.
- Patients with sufficient alveolar ridge height and width (no need for bone augmentation).
- Patients with sufficient inter-occlusal distance that will allow future restoration.
- Patients with healthy periodontium.
You may not qualify if:
- Smokers.
- Para functional habits.
- Bad oral hygiene measured according to O'Leary plaque index.
- Pregnant women.
- Other local or systemic diseases that may compromise the surgical procedure, healing or osteointegration.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Outpatient Clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University
Alexandria, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant lecturer of DPH and Clinical statistician
Study Record Dates
First Submitted
November 7, 2021
First Posted
November 18, 2021
Study Start
February 11, 2021
Primary Completion
August 23, 2021
Study Completion
August 23, 2021
Last Updated
November 18, 2021
Record last verified: 2021-11